ArTara Therapeutics Aktie
WKN DE: A2PX49 / ISIN: US04300J1079
|
06.07.2026 14:40:34
|
Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio As CMO
(RTTNews) - Corbus Pharmaceuticals Holdings, Inc. (CRBP), a company focused on oncology and obesity, said on Monday that it has appointed Leonardo Viana Nicacio as Chief Medical Officer.
Prior to joining Corbus, Nicacio was the CMO of Protara Therapeutics Inc.(TARA), a clinical-stage developer of therapies for the treatment of cancer and rare diseases.
Prior to Protara, Nicacio served as Senior Vice President, Head of Clinical Development and Global Medical Affairs at Stemline Therapeutics, a subsidiary of the Menarini Group.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu ArTara Therapeutics Inc Registered Shs
| Keine Nachrichten verfügbar. |